Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with...

by Schiffer Lena, Schiffer Mario, Merkel Saskia, Schwarz Anke, Mengel Michael, Jürgens Christopher, Schroeder Christoph, Zoerner Alexander A, Püllmann Kerstin, Bröcker Verena, Becker Jan U, Dämmrich Maximilian E, Träder Jana, Großhennig Anika, Biertz Frank, Haller Hermann, Koch Armin, Gwinner Wilfried
Published 2012-10-01